Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 04:00PM ET
58.70
Dollar change
-2.35
Percentage change
-3.85
%
IndexRUT P/E28.64 EPS (ttm)2.05 Insider Own24.35% Shs Outstand6.89M Perf Week-11.64%
Market Cap486.54M Forward P/E- EPS next Y- Insider Trans-0.53% Shs Float5.50M Perf Month81.68%
Income15.91M PEG- EPS next Q- Inst Own59.72% Short Float16.23% Perf Quarter119.85%
Sales58.94M P/S8.25 EPS this Y- Inst Trans19.32% Short Ratio2.16 Perf Half Y100.14%
Book/sh11.99 P/B4.90 EPS next Y- ROA18.54% Short Interest0.89M Perf Year50.13%
Cash/sh1.54 P/C38.01 EPS next 5Y- ROE20.39% 52W Range20.88 - 79.45 Perf YTD32.54%
Dividend Est.- P/FCF26.90 EPS past 5Y31.99% ROI18.64% 52W High-26.12% Beta1.19
Dividend TTM- Quick Ratio3.09 Sales past 5Y26.97% Gross Margin88.05% 52W Low181.13% ATR (14)7.59
Dividend Ex-Date- Current Ratio3.14 EPS Y/Y TTM-21.25% Oper. Margin34.02% RSI (14)62.08 Volatility16.47% 16.14%
Employees92 Debt/Eq0.00 Sales Y/Y TTM-11.93% Profit Margin27.00% Recom1.00 Target Price40.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q2.34% Payout0.00% Rel Volume1.88 Prev Close61.05
Sales Surprise3.15% EPS Surprise50.00% Sales Q/Q-17.19% EarningsNov 04 AMC Avg Volume412.91K Price58.70
SMA2020.26% SMA5067.08% SMA20083.93% Trades Volume777,388 Change-3.85%
Date Action Analyst Rating Change Price Target Change
Nov-02-22Downgrade B. Riley Securities Buy → Neutral $60 → $45
Nov-26-24 02:03PM
Nov-25-24 07:00AM
Nov-21-24 04:21PM
Nov-18-24 12:19PM
08:00AM
11:50PM Loading…
Nov-05-24 11:50PM
08:00AM
Nov-04-24 04:01PM
Oct-21-24 04:01PM
Aug-26-24 08:03AM
Aug-12-24 10:18AM
Aug-05-24 08:59PM
04:01PM
Jul-22-24 04:05PM
Jun-10-24 05:32PM
04:58PM Loading…
Jun-06-24 04:58PM
May-28-24 09:03AM
May-23-24 05:42AM
May-08-24 11:17AM
May-07-24 09:57PM
06:25PM
04:01PM
Apr-23-24 08:03AM
Mar-07-24 01:57PM
09:38AM
Mar-05-24 08:51PM
04:01PM
Feb-21-24 08:03AM
Feb-19-24 11:14AM
Nov-11-23 10:48AM
04:01PM Loading…
Nov-09-23 04:01PM
Oct-26-23 04:01PM
Sep-14-23 01:08PM
Aug-31-23 04:01PM
Aug-10-23 04:01PM
Jul-28-23 08:03AM
Jul-11-23 08:03AM
Jun-23-23 04:01PM
May-10-23 04:01PM
May-01-23 04:01PM
Apr-28-23 04:01PM
Apr-19-23 04:01PM
Apr-05-23 08:03AM
Apr-03-23 08:01AM
Mar-21-23 04:05PM
04:01PM
Mar-10-23 08:03AM
Mar-01-23 04:01PM
Dec-14-22 08:03AM
Dec-12-22 08:05AM
Nov-01-22 04:01PM
Oct-19-22 04:01PM
Aug-31-22 08:03AM
Aug-16-22 06:35AM
Aug-02-22 04:01PM
Jul-21-22 08:03AM
Jun-30-22 07:48AM
May-23-22 10:31AM
May-05-22 10:10AM
May-02-22 07:15PM
04:01PM
Apr-19-22 08:03AM
Apr-07-22 08:03AM
Mar-30-22 03:43PM
Mar-14-22 04:01PM
Mar-01-22 08:01AM
Feb-28-22 04:01PM
12:38PM
Feb-17-22 08:03AM
Jan-25-22 05:38PM
Jan-21-22 08:59AM
Jan-19-22 09:38AM
Dec-28-21 09:38AM
Dec-21-21 09:38AM
Dec-16-21 10:58AM
09:38AM
Dec-08-21 09:38AM
Nov-01-21 04:01PM
Oct-22-21 08:03AM
Oct-15-21 06:58AM
Sep-30-21 12:40PM
Sep-27-21 08:03AM
Sep-06-21 08:46AM
Aug-27-21 09:19AM
09:18AM
08:45AM
Aug-26-21 08:03AM
Aug-17-21 10:08AM
Aug-02-21 07:25PM
04:01PM
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers' patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Murphy-Chutorian DouglasCEONov 07 '24Option Exercise2.33100,000233,000100,000Nov 12 06:06 AM
Murphy-Chutorian DouglasCEONov 07 '24Sale37.9350,0001,896,50050,000Nov 12 06:06 AM
SEMLER ERICDirectorNov 07 '24Buy37.9350,0001,896,500621,721Nov 12 06:05 AM
Murphy-Chutorian DouglasCEOAug 29 '24Sale28.3510,000283,45360,220Aug 30 06:11 PM
Murphy-Chutorian DouglasCEOAug 28 '24Sale28.3278022,08770,220Aug 30 06:11 PM
DOUGLAS MURPHY-CHUTORIANOFFICERAug 29 '24Proposed Sale28.3510,000283,453Aug 29 07:54 PM
DOUGLAS MURPHY-CHUTORIANOFFICERAug 28 '24Proposed Sale28.3278022,087Aug 29 07:53 PM
Murphy-Chutorian DouglasCEOAug 26 '24Option Exercise2.1071,000149,10071,000Aug 27 04:50 PM